GW Pharmaceuticals Plc (NASDAQ:GWPH) reported Q4 2016 financial results this morning before the open, and although they beat analyst expectations, GWPH still posted a loss of -$0.89 per share on revenues of $2.2 million. The average analyst estimate as calculated by Zacks Investment Research was an expectation of -$1.48 per share.
While the results beat the analyst expectations, losses are losses and the pre-market trading shows it. As of the time of writing this article, shares of GWPH are down -$4.06 or -3.61% to $108.26 per share. This movement is based on just under 13,000 shares traded, with a pre-market low of 108.01.
For more information and coverage on GW Pharmaceuticals, be sure to check out their marijuana stock profile in our rapidly growing marijuana stocks database. For more pre-market trading information for GWPH from Nasdaq, click here. For the Associated Press article reporting the results, click here.